{"docstore/metadata": {"dcccb590-ced7-4448-be67-8ee7b08feb32": {"doc_hash": "8d82811b8e666098486fe696e790f06251c0b5b966a410546054b42c087c99b1"}, "25d082c3-d393-4ad8-a079-1e89e75c3a90": {"doc_hash": "19aaa9d00207bbb6b3541f85b970d7374dbb38ecd17705ec17dc9595c5d4e4e4"}, "157678dc-b38b-4693-b309-53b462c7d973": {"doc_hash": "4d55c05d3175848ac077671bdcb4af8d13a2a9f07300b6f2eafeeb36f3204659"}, "ce7f02c9-a003-4187-8c05-693f2a35c93e": {"doc_hash": "04397f280f9914df76761c872184e8135ae197153875bfc833c630020cbd33fd"}, "0a9fc226-d7bc-402d-b751-055d250fdb2c": {"doc_hash": "ec6a318e1b81359ed1a92283a04eafb9cb38f2e05ecba5faf2f690f6cb578e73"}, "b7a39a85-e773-4c06-806b-4fb87fe99659": {"doc_hash": "e9cb1d1a6f2dd83c7169eee316a6650c8a9862a6c79f52c09ceb0980cc7b5ed1"}, "17c63419-d9b7-4961-9dec-9f6bb88a73bd": {"doc_hash": "c0bf570fac52316aee5421880988264dd6f54eb29f499a658c15a82cb1737a22"}, "96f2ff6b-ee85-4340-81f6-dd6113e94fe2": {"doc_hash": "7e2c477674d2c879b21b5e342e4bf2abc02d7e7fa8b29f038c275b98fca5ccf8"}, "fba8bad4-3a45-41a8-9224-94c571042533": {"doc_hash": "7bd8975fe026a23a5ceb56481fd27ae734ff2845544aaadc98e4f33222230d5c", "ref_doc_id": "dcccb590-ced7-4448-be67-8ee7b08feb32"}, "3c22b8fc-c33f-4bb4-9b3b-959b594afbf7": {"doc_hash": "1a0ae2861a77c3536072a8e4dfefdc4437137e1d811ce3305f1e3513b2bc91be", "ref_doc_id": "dcccb590-ced7-4448-be67-8ee7b08feb32"}, "2b971f14-46c7-49f1-ba05-b2a52950a828": {"doc_hash": "e58b2c115bf71e459b8744b6dd6f38f83705dfdc973ad30afb89e1244baac30d", "ref_doc_id": "25d082c3-d393-4ad8-a079-1e89e75c3a90"}, "df3543ea-04ae-48bc-9b7d-f5e36d4cce6b": {"doc_hash": "692fa60e9519e27e9846a66f351aa786a8a2e880cf057d912e2920664a7de7e4", "ref_doc_id": "25d082c3-d393-4ad8-a079-1e89e75c3a90"}, "e277d928-6806-42d8-a6b7-1d4425d45b3e": {"doc_hash": "23d4942afea0ba964920192f54106af872b978d09c3c6014fd720aa1f029b34f", "ref_doc_id": "157678dc-b38b-4693-b309-53b462c7d973"}, "5d2a5bf1-d552-412f-ae29-0034b717760e": {"doc_hash": "4529894dacd6335958d166944797df2f47639b5d923eb371a17922f7472eef0a", "ref_doc_id": "157678dc-b38b-4693-b309-53b462c7d973"}, "791b4551-a4f6-4561-827a-1e85866ed80d": {"doc_hash": "65e98c96f0ef7350a8a1d8df25b0122d908919885aef79dad3147b618afdcc3c", "ref_doc_id": "ce7f02c9-a003-4187-8c05-693f2a35c93e"}, "6f61f65c-0662-4e27-b65c-cf9de9ad1028": {"doc_hash": "e4396c0672bd24e1f9a43eaf8314f57fb7657e42d8eb4a17685bbfb1d15e79d0", "ref_doc_id": "ce7f02c9-a003-4187-8c05-693f2a35c93e"}, "499d6266-adcb-4074-b6a8-7e4a6012a260": {"doc_hash": "a0a9f235c3961d1d8bf211dc426405a6823487c49d69c5a4d446cd8cf522cf66", "ref_doc_id": "0a9fc226-d7bc-402d-b751-055d250fdb2c"}, "6e631bfa-8786-44e5-9505-5426e3e2a57b": {"doc_hash": "3a3108bd3faebedce458c249d621d0c6c07e52f636de233dcc2564e09c8fb24f", "ref_doc_id": "0a9fc226-d7bc-402d-b751-055d250fdb2c"}, "1ee34727-4c38-46e1-abfa-61ac9b295d41": {"doc_hash": "82a1e0dd4dad753d5a2b389dff842e03c876a55783895f2fe2c15890e7a6a227", "ref_doc_id": "b7a39a85-e773-4c06-806b-4fb87fe99659"}, "15aaa61a-7d06-4c67-92f4-a3213c3ea6b5": {"doc_hash": "56236097dcef2778ec1cc19f890c54ebf1bbd41a3c2d79104bacfb86b3a165f7", "ref_doc_id": "b7a39a85-e773-4c06-806b-4fb87fe99659"}, "b6a482a4-39a1-4c0a-bfa4-56b4654b2406": {"doc_hash": "a0c2d23c984313fdaabe75bcef0ced0428d1f560562b33ac3e2a76ff4cf659c4", "ref_doc_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd"}, "e36249d4-a6cc-484b-93ea-81771537fa34": {"doc_hash": "0bfe42f1dbf17947dfac2316537cd5a9782301a4130ac271c20ee16285cd3acb", "ref_doc_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd"}, "50cdda02-4c5c-445c-b8b2-a15b3b0dfa72": {"doc_hash": "4fbb23a460a27b607ca2438ae031cbf24a3efecdcc4286b0dd883dcdf6d58365", "ref_doc_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd"}, "fa7b8e0b-3ac2-41bb-8b09-257bcc67c0ee": {"doc_hash": "3ae31459cb646c00137dc4533a71956569c7e1b440a71f04e8889a212fce3549", "ref_doc_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2"}, "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821": {"doc_hash": "168e58394944bef49bd115745630b3007e62543f9b22054c4519b62a858a132a", "ref_doc_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2"}, "3cc43232-01ca-4d26-949c-d65fe0b67268": {"doc_hash": "3687d91b525ef1cf075762459c182c6ec950c702951948d41015eae9cb72f6df", "ref_doc_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2"}}, "docstore/data": {"fba8bad4-3a45-41a8-9224-94c571042533": {"__data__": {"id_": "fba8bad4-3a45-41a8-9224-94c571042533", "embedding": null, "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, HER-2/neu Oncogene, Amplification, Relapse, Survival"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dcccb590-ced7-4448-be67-8ee7b08feb32", "node_type": "4", "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "8d82811b8e666098486fe696e790f06251c0b5b966a410546054b42c087c99b1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3c22b8fc-c33f-4bb4-9b3b-959b594afbf7", "node_type": "1", "metadata": {}, "hash": "02a776a47a9a4ef41b05c2d423aa634c87e4cffdfb9ed177e374bbe35d503345", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/19364043\nSlamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WLHuman breast\ncancer: correlation of relapse and survival with ampli\ufb01cation of the HER-2/neu\noncogene. Science (Wash DC...\nArticle\u00a0\u00a0in \u00a0\u00a0Science \u00b7 February 1987\nDOI: 10.1126/science.3798106\u00a0\u00b7\u00a0Source: PubMed\nCITATIONS\n9,991\nREADS\n29,239\n6 authors, including:\nGary Clark\nGary Clark Statistical Consulting, LLC\n364 PUBLICATIONS\u00a0\u00a0\u00a069,933 CITATIONS\u00a0\u00a0\u00a0\nSEE PROFILE\nSteven G Wong\nUniversity of California, Los Angeles\n24 PUBLICATIONS\u00a0\u00a0\u00a025,028 CITATIONS\u00a0\u00a0\u00a0\nSEE PROFILE\nWendy Levin\nFate Therapeutics, Inc.\n25 PUBLICATIONS\u00a0\u00a0\u00a017,999 CITATIONS\u00a0\u00a0\u00a0\nSEE PROFILE\nAll content following this page was uploaded by Gary Clark on 23 December 2013.\n", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 806, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "3c22b8fc-c33f-4bb4-9b3b-959b594afbf7": {"__data__": {"id_": "3c22b8fc-c33f-4bb4-9b3b-959b594afbf7", "embedding": null, "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "\"Breast Cancer\", \"Gene Expression\", \"Oncology\", \"Tumor Markers\", \"Molecular Biology\""}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "dcccb590-ced7-4448-be67-8ee7b08feb32", "node_type": "4", "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "8d82811b8e666098486fe696e790f06251c0b5b966a410546054b42c087c99b1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fba8bad4-3a45-41a8-9224-94c571042533", "node_type": "1", "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "efbb6dc3f6b4e1d69c9dfe1d5bd45634131ed891b7c5c8d53756c8d2ba7c12fb", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The user has requested enhancement of the downloaded file.", "mimetype": "text/plain", "start_char_idx": 806, "end_char_idx": 864, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "2b971f14-46c7-49f1-ba05-b2a52950a828": {"__data__": {"id_": "2b971f14-46c7-49f1-ba05-b2a52950a828", "embedding": null, "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, HER-2/neu Oncogene, Survival Rate, Amplification, Science Magazine (1987)"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "25d082c3-d393-4ad8-a079-1e89e75c3a90", "node_type": "4", "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "19aaa9d00207bbb6b3541f85b970d7374dbb38ecd17705ec17dc9595c5d4e4e4", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "df3543ea-04ae-48bc-9b7d-f5e36d4cce6b", "node_type": "1", "metadata": {}, "hash": "ff0fab28f65e78b98e143a1489fd3d3b026a73dc12f2bcee96145fb50f8c3205", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "DOI: 10.1126/science.3798106 \n, 177 (1987); 235Science\n  et al.DJ Slamon,\noncogene\nsurvival with amplification of the HER-2/neu \nHuman breast cancer: correlation of relapse and\n www.sciencemag.org (this information is current as of January 15, 2007 ):\nThe following resources related to this article are available online at\n http://www.sciencemag.org\nversion of this article at: \n including high-resolution figures, can be found in the onlineUpdated information and services,\n http://www.sciencemag.org#otherarticles\n, 15 of which can be accessed for free: cites 37 articlesThis article \n http://www.sciencemag.org#otherarticles\n 99 articles hosted by HighWire Press; see: cited byThis article has been \n http://www.sciencemag.org/help/about/permissions.dtl\n in whole or in part can be found at: this article\npermission to reproduce of this article or about obtaining reprintsInformation about obtaining \nregistered trademark of AAAS. \nc 2006 by the American Association for the Advancement of Science; all rights reserved. ", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1024, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "df3543ea-04ae-48bc-9b7d-f5e36d4cce6b": {"__data__": {"id_": "df3543ea-04ae-48bc-9b7d-f5e36d4cce6b", "embedding": null, "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. \"Slamon et al.\", \"SCIENCE 1987\", \"American Association for the Advancement of Science\", \"Biom 255 (Leffert)\", \"Discussion Feb. 1, 2007\""}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "25d082c3-d393-4ad8-a079-1e89e75c3a90", "node_type": "4", "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "19aaa9d00207bbb6b3541f85b970d7374dbb38ecd17705ec17dc9595c5d4e4e4", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "2b971f14-46c7-49f1-ba05-b2a52950a828", "node_type": "1", "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "eb2b2b16742d46884a619329b832b2814e305d9a887c0f6348a1c989f2bb981e", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "The title SCIENCE is a \nCopyrightAmerican Association for the Advancement of Science, 1200 New York Avenue NW, Washington, DC 20005. \nScience (print ISSN 0036-8075; online ISSN 1095-9203) is published weekly, except the last week in December, by the\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. 1, 2007", "mimetype": "text/plain", "start_char_idx": 1024, "end_char_idx": 1374, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "e277d928-6806-42d8-a6b7-1d4425d45b3e": {"__data__": {"id_": "e277d928-6806-42d8-a6b7-1d4425d45b3e", "embedding": null, "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu Oncogene, Breast Cancer, Gene Amplification, Survival Rate, Prognostic Factors"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "157678dc-b38b-4693-b309-53b462c7d973", "node_type": "4", "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "4d55c05d3175848ac077671bdcb4af8d13a2a9f07300b6f2eafeeb36f3204659", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "5d2a5bf1-d552-412f-ae29-0034b717760e", "node_type": "1", "metadata": {}, "hash": "1c0de0b14ba5c3feecb1e324ef2e2dd08acd7a0df8194d96fa722b105342079d", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Human BreastCancer: Correlationof\nRelapse and Survival with Amplification\nof theHER-2lneu Oncogene\nDENNISJ.SLAMON,*GARYM.CLARK,STEVENG.WONG,WENDYJ.LEVIN,\nAxELULLRICH,WILLiAML.McGuIRE\nTheHER-2/neuoncoFeneisamemberoftheerbB-likeoncogenefamily,andaSrelatedto,butdistinctfirom,the\nepidermalgrowthfactorreceptr.Thisgenehasbeen\nshowntobeamplifiedihumanbrt cancercelllines.\nInthecurrentstudy,alterationsofthegenein189primaryhumanbreastcancerswereinstigatedHER-2/neuwasfoundtobeamplifiedfrm2-to eaterthan20-\nfoldin30%ofthetumors.Correlationofgeneamplifica-tionwithseveraldiseaseparameterswasevaluatedAm-\nplificationoftheHER-2/neugenewasasignificantpre-\ndictorofbothoverallsurvivalandtimetorelapsein\npatientswithbreastcancer.Itretaineditssignificanceevenwhenadjustmentsweremadeforotherknownprognosticfactors.Moreover,HER-2/neuamplificationhadgreaterprognosticvaluethanmostcurrentlyusedprognosticfactors,incudinghormonal-receptorstatus,\ninlymphnode-positivedisease.Thesedataindicatethat\nthbisgenemaylayaroleinthebiologicbehaviorand/or\npathogenesishumanbreastcancer.\nHEEVIDENCELINKINGPROTO-ONCOGENESTOTHEINDUC-\ntionormaintenanceofhumanmalignanciesislargelycir-\ncumstantial,buthasbecomeincreasinglycompelling.This\ncircumstantialevidenceisderivedfromstudiesofanimalmodels,\ntumorcelllines,andactualhumantumors.Datafromanimalmodels\nandcelllinesinclude:(i)sequencehomologybetweenhumanproto-\noncogenesandtheviraloncogenesoftransformingretrovirusesthat\nareknowntobetumorigenicinsomespecies(1,2);(ii)transfction\nstudiesshowingthetransformingpotentialofproto-oncogenesm\nNIH3T3cellsandprimaryembryofibroblasts(3-5);and(iii)the\ncentralroleofcertainproto-oncogenesintumorigenesisbychronic\ntransformingretrovirusessuchasavianleukosisvirus(6).Datafrom\nhumantumorsinclude:(i)increasedexpressionofspecificproto-\noncogenesinsomehumanmalignancies(7,8);(ii)localizationof\nproto-oncogenesatornearthesiteofspecific,tumor-associated\nchromosomaltranslocations(9);and(iii)amplificationofproto-\noncogenesinsomehumantumors(10,11).\nAdditionaldatalinkingproto-oncogenestocellgrowthistheir\nexpressioninresponsetocertainproliferationsignals(12,13)and\ntheirexpressionduringembryonicdevelopment(14,15).More\ndirectevidencecomesfromthefactthat,ofthe20knownproto-\noncogenes,threearerelatedtoagrowthfactororagrowthfactor\nreceptor.Thesegenesincludec-sis,whichishomologoustothe\n9jANUARYI987\ntransforminggeneofthesimiansarcomavirusandisthe1Bchainof\nplatelet-derivedgrowthfactor(PDGF)(16,17);c-fis,whichis\nhomologoustothetransforminggeneofthefelinesarcomavirus\nandiscloselyrelatedtothemacrophagecolony-stimulatingfactor\nreceptor(CSF-1R)(18);andc-erbB,whichencodestheEGF\nreceptor(EGFR)andishighlyhomologoustothetransforming\ngeneoftheavianerythroblastosisvirus(19).Thetworeceptor-\nrelatedproto-oncogenes,c-finsandc-erbB,aremembersofthe\ntyrosine-specificproteinkinasefamilytowhichmanyproto-onco-\ngenesbelong.\nRecently,anoveltransforminggenewasidentifiedasaresultof\ntransfctionstudieswithDNA fromchemicallyinducedratneu-\nroglioblastomas(20).Thisgene,calledneu,wasshowntoberelated\nto,butdistinctfrom,thec-erbBproto-oncogene(21).Bymeansof\nv-erbBandhumanEGFRasprobestoscreenhumangenomicand\ncomplementaryDNA(cDNA)libraries,twoothergroupsindepen-\ndentlyisolatedhumanerbB-relatedgenesthattheycalledHER-2\n(22)andc-erbB-2(23).Subsequentsequenceanalysisandchromo-\nsomalmappingstudiesrevealedallthreegenes(neu,c-erbB-2,and\nHER-2)tobethesame(22,24,25).Afourthgroup,alsousingv-\nerbBasaprobe,identifiedthesamegeneinamammarycarcinoma\ncellline,MAC 117,whereitwasfoundtobeamplifiedfive-toten-\nfold(26).\nThisgene,whichwewillcallHER-2/neu,encodesanewmember\nofthetyrosinekinasefamily;andisdoselyrelatedto,butdistinct\nfrom,theEGFRgene(22).HER-2/neudiffersfromEGFRinthatit\nisfoundonbandq21ofchromosome17(22,24,25),ascompared\ntobandpll.-p13ofchromosome7,wheretheEGFRgeneis\nlocated(27).Also,theHER-2/neugenegeneratesamessenger\nRNA(mRNA)of4.8kb(22),whichdiffersfromthe5.8-and10-\nkbtransciptsfortheEGFRgene(28).Finally,theproteinencoded\nbytheHER-2/neugeneis185,000daltons(21),ascomparedtothe\n170,000-daltonproteinencodedbytheEGFRgene.Conversely,on\nthebasisofsequencedata,HER-2/neuismorecloselyrelatedtothe\nEGFRgenethantoothermembersofthetyrosinekinasefamily\n(22).LiketheEGFRprotem,HER-2/neuhasanextracellular\ndomain,atransmembranedomainthatincludestwocysteine-rich\nrepeatdusters,andanintracellularkinasedomain(21),indicating\nD.J.Slamon,S.G.Wong,andW.J.LevinareintheDivisionofHematology-Oncokogy,DepartmentofMedicineandJonssonComprehensiveCancerCenter,UCLASchoolofMedicine,LosAngcels,CA90024.G.AM.ClarkandW.L.McGuireareintheDivisionofOncology,DepartmentofMedicine,UniversityofTexasHealthScienceCcnteratSanAntonio,SanAntonio,TX78284.A.UtlrichisintheDeparmenetofMolecularBiology,Gcnentech,Inc.,SouthSanFrancisco,CA94080.\n*Towhomcorrespondenceshouldbeaddressed.\n", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 4778, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "5d2a5bf1-d552-412f-ae29-0034b717760e": {"__data__": {"id_": "5d2a5bf1-d552-412f-ae29-0034b717760e", "embedding": null, "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Slamon et al., Science 1987, PDF Document\n   2. Breast Cancer, Oncology, Tumor Markers\n   3. Gene Expression, Genetic Profiling, Biomarkers\n   4. Adjuvant Chemotherapy, Treatment Efficacy, Clinical Trials\n   5. Prognostic Factors, Risk Assessment, Cancer Research"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "157678dc-b38b-4693-b309-53b462c7d973", "node_type": "4", "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "4d55c05d3175848ac077671bdcb4af8d13a2a9f07300b6f2eafeeb36f3204659", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e277d928-6806-42d8-a6b7-1d4425d45b3e", "node_type": "1", "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "e5874066e3b14d459f1773a104553e57c4d71e7719a425d7a28252d9cfb0b017", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "ARTICLES177\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. 1, 2007", "mimetype": "text/plain", "start_char_idx": 4778, "end_char_idx": 4890, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "791b4551-a4f6-4561-827a-1e85866ed80d": {"__data__": {"id_": "791b4551-a4f6-4561-827a-1e85866ed80d", "embedding": null, "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification,\n   2. Breast cancer,\n   3. Oncogene abnormalities,\n   4. Southern blot analysis,\n   5. Prognosis of breast malignancies"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ce7f02c9-a003-4187-8c05-693f2a35c93e", "node_type": "4", "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "04397f280f9914df76761c872184e8135ae197153875bfc833c630020cbd33fd", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6f61f65c-0662-4e27-b65c-cf9de9ad1028", "node_type": "1", "metadata": {}, "hash": "f39dad4c2dfecd9e760581508d14ac0b08af5bf24ce86ed46ee43d151ccce266", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "thatittooislikelytobeacellularreceptorforanasyetunidentified\nligand.\nAsaresultofthepublisheddatashowingamplificationofHER-\n2/neuinahumanmammarycarcinomacellline,andaspartofan\nongoingsurveyinourlaboratoryofproto-oncogeneabnormalities\ninhumantumors,weevaluatedalterationsoftheHER-2/neugene\ninalargeseriesofhumanprimarybreastcancers.Ourresultsshow\nthatamplificationofthisgeneoccursrelativelyfrequentlyinbreast\ncancer,andthatitisassociatedwithdiseaserelapseandoverall\npatientsurvival.\nFactorsthatareknowntobeimportantintheprognosisofbreast\nmalignanciesinindividualpatientsinclude:sizeoftheprimary\ntumor,stageofdiseaseatdiagnosis,hormonalreceptorstatus,and\nnumberofaxillarylymphnodesinvolvedwithdisease(positive\nnodes)(29).Thecurrentstudy,whichwasconductedintwoparts,\ninvolvedtheevaluationoftissuefrom189separatebreastmalignan-\nciesthatwerepartofabreastcancerstudyongoingattheUniversity\nofTexas,SanAntonio.Thiscohortoftumorswasofinterest\nbecauseconsiderableinformationwasavailableonthemajorityof\nthespecimensincludingsizeoftheprimarytumor,estrogenrecep-\ntorstatus,progesteronereceptorstatus,ageofpatient,diseasestage,\nandstatusoftheaxillarylymphnodes.\nIntheinitialsurvey,tissuefrom103primarybreastcancerswas\nevaluatedforalterationsintheHER-2/neugene.DNA from\nindividualtumorswaspreparedasdescribed(30),digestedwith\nEcoRI,andsubjectedtoSouthernblotanalysiswitha32P-labeled\nHER-2/neu-1probe,whichisknowntodetecta13-kbhybridizing\nbandinhumanDNA (22).Examplesoftumorsfromtheinitial\nsurveyareshowninFig.1.Ofthe103samplesexamined,19(18%)\nshowedevidenceofHER-2/neugeneamplification.Thedegreeof\namplificationinindividualcaseswasdeterminedbydilutionanalysis\n(Fig.2A),aswellassoftlaserdensitometryscanning.Todetermine\nthattheamountofDNA loadedineachlanewasequivalent,all\nfilterswerewashedandrehybridizedwitha32P-labeledarginase\ngeneprobe(31).Thisprobeidentifiesa15-kbhybridizingbandon\nEcoRI-digestedhumanDNA,andwasselectedasacontrol\nbecauseitmoreappropriatelyassessestherelativeamountand\nFig.1.AnalysisofalterationsoftheHER-2/neu\ngeneinhumanbreastcancer.Shownare79ofthe\n189breasttumorsusedinthisanalysis.Tumors\nwithasinglecopyofHER-2/neu:3,4,10to15,\n20,23to25,27to29,31,38,42to46,48,49,\n52,55,61,65,66,71,72,and74.Tumorswith\ntwotofivecopiesofHER-2/neu:1,2,5,7,9,16,\n17,19,21,22,32,35,36,47,50,54,56to58,\n60,62,70,and75to77.Tumorswith5to20\ncopiesofHER-2/neu:6,8,26,34,37,39to41,\n51,53,63,64,67,69,73,and79.Tumorswith\nmorethan20copiesofHER-2/neu:18,30,33,\n59,68,and78.Examplesoftumors77to79have\nrearrangementsintheHER-2/neugene.DNA\nwasextractedfromtissuesanddigestedwithEco\nRIasdescribed(30).Atotalof12,ugofEcoRI-\ndigestedDNA wasloadedonto0.8%agarose\ngels,separatedbyelectrophoresis,andtransferred\nontonylonfilterpapers(Biodyne)(30).Allfilters\nwerebakedinavacuumovenfor3hoursat80\u00b0C,\nprehybridizedin5x SSC(standardsalinecitrate)\ncontaining50%formamide,10%dextransulfate,\n0.1%SDS,denaturedsalmonspermDNA(1mg/\nmnl),and4x Denhardtssolutionfor12hours,\nthenhybridizedinthesamesolutioncontaining\n32P-labelednick-translatedHER-2probe(21)\nspecificactivityof1x 108cpmpermicrogramof\nDNA;2x 106cpm/ml.Hybridizationoccurred\nat42\u00b0Cfor48hours,followedbywashingof\nfiltersunderthefollowingconditionsinsucces-\n178\nTable1.AssociationbetweenHER-2lneuamplificationanddiseaseparame-\ntersin103breasttumors.\nNumberoftumors\nFactor*Single2to5 5 to20 >20 TotalPt\ncopy copies copies copies\nHormonalreceptorstatus\nER+ 53 2 9 1 65 0.99\nER- 31 1 2 4 38\nPgR+ 42 2 6 2 52 0.85\nPgR- 42 1 5 3 51\nTumorsize(centimate,r)\nc<2 13 1 1 0 15 0.82\n2-5 34 1 5 1 41\n>5 17 1 2 2 22\nUnknown 20 0 3 2 25\nAgeatdiagnosis(yeats)\nc50 21 1 2 1 25 0.83\n>50 52 2 7 4 65\nUnknown 11 0 2 0 13\nNumberofpositiveIymhnodes\n0 30 0 3 1 34 0.11\n1-3 20 0 1 1 22\n>3 17 2 4 2 25\nUnknown 17 1 3 1 22\n*Receptorstatuswasanalyzedasdescribed(39).ER,estrogenreceptor:+and- refer\ntotheprcsenceorabsenceof:3fmolofreceptorpermilligramofprotein.PgR,progesteronereceptor:+and- referstothepresenceorabsenceof25fmolofreceptorpermilL:amofprotein.tStatisticalanaf,sesforcorrelationofHER-2/neuamplifi-cationwithdiscaseparameterswereperformedbythex2test.Pvalueswerecomputedaftercombiningthecaseswith5to20and>20copies.\ntransferofhighmolecularweightspeciesthanaprobehybridizing\nwithlowmolecularweightspecies,whichtransfermorereadilyon\nSouthernblotting.Alllaneswereshowntocontainequivalent\namountsofhighmolecularweightDNA (Fig.2B).Individual\ntumorswereassignedtogroupscontainingasinglecopy,2to5\ncopies,5to20copies,andgreaterthan20copiesoftheHER-2/neu\ngene(Fig.1).Assignmentoftumorstothevariousgroupswasdone\nu _ 0-S;0,-M;60S_tJ~~~~~~~~~~kbtN~~~~~~~~~~~~~~~~-12\nsion:2xSSCfor20minutesatroomtempera-0.5xSSC,0.1%SDSat650C.Filterswerethen\nture;twowashesof30minuteseachin2x SSC,exposedtoXAR-5x-rayfilm(Kodak)forautora-\n0.1%SDSat65\u00b0C;onewashof30minutesin diography.\nSCIENCE,VOL.235\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. ", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 4863, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "6f61f65c-0662-4e27-b65c-cf9de9ad1028": {"__data__": {"id_": "6f61f65c-0662-4e27-b65c-cf9de9ad1028", "embedding": null, "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, 1987 Study, Slamon et al., Science, Gene Expression"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "ce7f02c9-a003-4187-8c05-693f2a35c93e", "node_type": "4", "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "04397f280f9914df76761c872184e8135ae197153875bfc833c630020cbd33fd", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "791b4551-a4f6-4561-827a-1e85866ed80d", "node_type": "1", "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "4af324644d29d6c82a3335e69ed228668eea976b5b222f2a027e37c03ec21181", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1, 2007", "mimetype": "text/plain", "start_char_idx": 4863, "end_char_idx": 4870, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "499d6266-adcb-4074-b6a8-7e4a6012a260": {"__data__": {"id_": "499d6266-adcb-4074-b6a8-7e4a6012a260", "embedding": null, "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification, Breast cancer, Gene amplification analysis, Axillary lymph nodes, Multivariate regression analysis"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0a9fc226-d7bc-402d-b751-055d250fdb2c", "node_type": "4", "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "ec6a318e1b81359ed1a92283a04eafb9cb38f2e05ecba5faf2f690f6cb578e73", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "6e631bfa-8786-44e5-9505-5426e3e2a57b", "node_type": "1", "metadata": {}, "hash": "ad73401a1323c8a2d5551e21ca3515e712f8a927c689325fca8265111405c4de", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Fig.2.(A)ExampleofdilutionalanalysistoassessdegreeofHER-2/neu\ngeneamplification.Lanesa,g,k,andpwereloadedwith12,ugofEcoL1-\ndigestedbreasttumorDNA.LaneaisDNAfromtumor31(Fig.1),which\nrepresentsatumorwithasinglecopyoftheHER/2-neugene.Lanegis\nDNA fromtumor33,whichrepresentsatumorwith>20copiesofthe\nHER-2/neugene.Lanesbtofareserialdilutions(1:100,1:20,1:10,1:5,\nand1:2,respectively)oftheDNA sampleinlaneg.LanekisDNA from\ntumor35(Fig.1),whichrepresentsatumorcontainingtwotofivecopiesof\ntheHER-2/neugene.Laneshtojareserialdilutions(1:10,1:5,and1:2,\nrespectively)oftheDNAsampleinlanek.LanepisDNAfromtumor34\n(Fig.1),whichrepresents atumorwith5to20copiesoftheHER-2/neu\ngene.LanesItooareserialdilutions(1:20,1:10,1:5,and1:2,respective-\nly)oftheDNAsampleinlanep.Thefilterwaspreparedandhybridizedwith\na P-labeledHER-2probeasinFig.1.(B)Exampleofarginaseprobe\nhybridizationtodemonstratethatequivalentamountsoftumorDNAwere\nloadedintoeachlane.Rehybridizationoffiltercontaininglanes30to40\n(Fig.1).Thefilterwasfirststrippedoflabelbywashinginabuffermadeup\nof50%formamide,3xSSC,and0.1%SDSat65\u00b0Cfor20minutes,followingbythreesuccessivewashesof5minuteseachin0.1xSSCatroom\ntemperature.FilterswereexposedovernightonXAR-5film(Kodak)to\nensureremovalofallradioactiveprobe,thenrehybridizedasinFig.1witha\n32P-labeledhumanarginasegeneprobe(31).\ninablindedfashion,inthattheyweremadewithoutknowledgeof\ndiseaseparameters.Analysisofthedataforassociationbetweengene\namplificationandanumberofdiseaseparameterswasthenper-\nformed.\nOf103tumorsevaluatedintheinitialsurvey,therewasessentially\nnocorrelationbetweengeneamplificationandestrogenreceptor\nstatus,progesteronereceptorstatus,sizeoftumors,orageat\ndiagnosis(Table1).However,whenanalysiswasperformedfor\nassociationbetweenHER-2/neuamplificationandnumberofposi-\ntivelymphnodes,atrendwasnoted.Thisanalysisshowedthat4/34\n(11%)ofpatientswithnoinvolvednodes,2/20(10%)with1to3\ninvolvednodes,and8/25(32%)with>3involvednodeshadgene\namplification(P= 0.11).Ifthesedatawereexaminedbycomparing\n0to3positivenodesversus>3positivenodes,thecorrelationwith\ngeneamplificationbecamemoresignificant(P<0.05).Thus,there\nwasasignificantincreaseinincidenceofHER-2/neugeneamplifica-\ntioninpatientswith>3axillarylymphnodesinvolvedwithdisease.\nAmultivariateregressionanalysistocorrelateHER-2/neuamplifica-\ntionwithvariousdiseaseparametersidentifiedthenumberof\npositivenodesastheonlysignificantfactor,eitheraloneorin\ncombination,tocorrelatewithamplification.\nThisinitialstudyindicatedthatitmightbepossibletodiscrimi-\nnateamongnode-positivepatientsonthebasisofHER-2/neugene\nA\na bc d e f g h i j k I m n o p\nB\namplification.Itiswellknownthatthenumberofpositivenodesis\nthebestprognosticfactorfordiseaserecurrenceandsurvivalin\npatientswithbreastcancer(29).Given.thecorrelationbetween\nnumberofnodespositiveandHER-2/neuamplification,onemight\npredictthatamplificationofthisgenemightalsohavesome\nprognosticvalue.No long-termfollow-updata,however,were\navailableonthe103patientsanalyzedintheinitialstudy.Forthis\nreason,asecondstudywasconductedon100breastcancersamples\nfrompatientswithpositiveaxillarylymphnodes.Alloftheinforma-\ntionavailableforthefirstgroupof103patientswasavailablefor\nthesepatients.Inaddition,relapseandsurvivalinformationwas\navailable,sincethesecaseshadamedianfollow-upof46months\n(range24to86months).Ofthese100samples,86yieldedsufficient\nDNA forstudy.AmplificationoftheHER-2/neugenewasmea-\nsuredasintheinitialsurvey,andexamplesoftumorsfromthisstudy\nareshown(Fig.1).Amplificationwasfoundin34/86(40%)of\nthesepatients.Forthislargersampleofnode-positivepatients,\nseveralstatisticallysignificantornearlysignificantrelationshipswere\nobserved.Inagreementwiththepreliminarysurvey,therewasan\nassociationbetweennumberofinvolvedlymphnodesandHER-2/\nneuamplification(Table2).Inaddition,thepresenceofgene\namplificationwascorrelatedwithestrogenreceptorstatusandsize\nofprimarytumor(Table2).Together,thesetwosurveysyielded\ndataon189patientsandtheassociationofHER-2/neuamplifica-\ntionwithvariousdiseaseparametersinthecombinedgroupis\nshowninTable3.\nWhilethesecorrelationswereofinterest,thestrongrelationship\n1.0-\nFig.3.Actuarialcurveforrelapsein(A)node-\npositivepatientswithnoamplificationversus\nnode-positivepatientswithanyamplification(>2\ncopies)ofHER-2/neuand(C)node-positivepa-\ntientswithnoamplificationversusnode-positive\npatientswithgreaterthan5copiesofHER-2/neu.\nActuarialcurveforoverallsurvivalin(B)node-\npositivepatientswithnoamplificationversus\nnode-positivepatientswithanyamplification(>2\ncopies)ofHER-2/neuand(D)node-positivepa-\ntientswithnoamplificationversusnode-positive\npatientswithgreaterthan5copiesofHER-2/neu.\nActuarialcurvesforbothrelapseandoverallsur-\nvivalwerecomputedbythemethodofKaplan\nandMeier(44)andcomparedbythelogranktest\n(42-44).\n9JANUARYI987\n>.0.8-\n0.6-\nCDton\n,, 0.4-'I\n30.2\n0\n1.0-\nc 0.8-\nI.\n", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 4797, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "6e631bfa-8786-44e5-9505-5426e3e2a57b": {"__data__": {"id_": "6e631bfa-8786-44e5-9505-5426e3e2a57b", "embedding": null, "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Amplified DNA, Notamplified DNA, Time (months), Articles, Science Magazine"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "0a9fc226-d7bc-402d-b751-055d250fdb2c", "node_type": "4", "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "ec6a318e1b81359ed1a92283a04eafb9cb38f2e05ecba5faf2f690f6cb578e73", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "499d6266-adcb-4074-b6a8-7e4a6012a260", "node_type": "1", "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "a82680d405fb2be8de4eacbce89026b96f3f71cda2e3d6b0deb05a0b92d87cf7", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "0 0.6-\n00.\nOX 0.4-\n` 0.2-\namplified(n=52)\nAmplified(n=34)\nA\nNotamplified(n=52)\nAmplified(n=34)\nB\n12 24 36 48 60 72 84\nNotamplified(n=52)\nAmplified(n=11)\n>5copies\nC\nNotamplified(n=52)\nAmplified(n=11)\n>5copies\nD\n12 24 36 48 60 72 84\nTime(months)\nARTICLES 179\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. 1, 2007", "mimetype": "text/plain", "start_char_idx": 4797, "end_char_idx": 5154, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "1ee34727-4c38-46e1-abfa-61ac9b295d41": {"__data__": {"id_": "1ee34727-4c38-46e1-abfa-61ac9b295d41", "embedding": null, "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu amplification,\n   2. Breast cancer,\n   3. Gene amplification,\n   4. Disease behavior,\n   5. Survival analysis"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b7a39a85-e773-4c06-806b-4fb87fe99659", "node_type": "4", "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "e9cb1d1a6f2dd83c7169eee316a6650c8a9862a6c79f52c09ceb0980cc7b5ed1", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "15aaa61a-7d06-4c67-92f4-a3213c3ea6b5", "node_type": "1", "metadata": {}, "hash": "f39dad4c2dfecd9e760581508d14ac0b08af5bf24ce86ed46ee43d151ccce266", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "betweenHER-2/neuamplificationandnodalstatus(P=0.002)\nindicatedthatinformationonamplificationofthisgenemay\ncorrelatewithdiseasebehavior;thatis,recurrencesandsurvival.To\ntestthis,univariatesurvivalanalyseswereperformedinwhich\namplificationwascomparedtorelapseandsurvivalinthispatient\ngroup.Atotalof35patientshadarecurrenceofthedisease,and29\nhaddiedatthetimeoftheanalyses.Mediantimestorelapseand\ndeathwere62monthsand69months,respectively.Themedian\nfollow-uptimeforpatientsstillalivewas47months,rangingfrom\n24to86months.Atotalof71ofthe86patients(83%)received\nsomeformoftherapyaftermastectomy:adjuvantsystemictherapy\nalone,47%;adjuvantsystemictherapypluslocalradiation,19%;\nandlocalradiationalone,17%.A strongandhighlystatistically\nsignificantcorrelationwasfoundbetweenthedegreeofgene\namplificationandbothtimetodiseaserelapse(P=<0.0001)and\nsurvival(P= 0.0011)(Table4).Moreover,whencomparedin\nunivariateanalysestootherparameters,amplificationofHER-2/neu\nwasfoundtobesuperiortoallotherprognosticfactors,withthe\nexceptionofthenumberofpositivenodes(whichitequaled)in\npredictingtimetorelapseandoverallsurvivalinhumanbreast\ncancer(Table4).TheassociationbetweenHER-2/neuamplification\nandrelapseandsurvivalcanbeillustratedgraphicallyinactuarial\nsurvivalcurves(Fig.3,A toD).Whiletherewasasomewhat\nshortenedtimetorelapseandshorteroverallsurvivalinpatients\nhavinganyamplificationoftheHER-2/neugeneintheirtumors\n(Fig.3,A andB),thegreatestdifferenceswerefoundwhen\ncomparingpatientswith>5copiesofthegenetothosewithout\namplification(singlecopy)(Fig.3,CandD).Patientswithgreater\nthanfivecopiesofHER-2/neuhadevenshorterdisease-freesurvival\ntimes(P= 0.015)andoverallsurvivaltimes(P= 0.06)when\ncomparedtopatientswithnoamplification.Thephenomenonof\ngreatergenecopynumbercorrelatingwithaworseprognosishas\nalsobeenseeninevaluationsofN-mycgeneamplificationinhuman\nneuroblastomas(32).\nTodetermineifamplificationofHER-2/neuwasindependentof\notherknownprognosticfactorsinpredictingdiseasebehavior,\nmultivariatesurvivalanalyseswereperformedonthe86node-\npositivecases.Amplificationofthegenecontinuedtobeastrong\nprognosticfactor,providingadditionalandindependentpredictive\ninformationonbothtimetorelapseandoverallsurvivalinthese\nTable2.AssQciationbetweenHER-2/neuamplificationanddisaseparame-\ntersin86breasttumorsfromnode-positivepatients.\nFactor*Single2to5 5to20 >20 Total Ptcopy copies copiescopies\nHomonalreceptorstatu\nER+ 38 21 5 1 65 0.05\nER- 14 2 4 1 21\nPgR+ 31 18 4 1 54 0.14\nPgR- 21 5 5 1 32\nTumorsize(centimeters)\n<2 18 8 3 0 29 0.09\n2-5 28 12 2 1 43\n>5 6 3 4 1 14\nAgeatdiagnosis(years)\n50 16 12 6 1 35 0.06\n>50 36 11 3 1 51\nNumberofpositivelymphnodes\n1-3 31 7 5 0 43 0.06>3 21 16 4 2 43\nFig.4.ExampleofrehybridizationoffilterwithhumanEGFRprobe.Filters\nwerestrippedasinFig.2B,andhybridizedwith32P-labeledhumanEGFR\nprobe(28),asinFig.1.Shownarethelowermolecularweightbands\nhybridizedwith32P-labeledEGFRprobeinfilter-containinglanes51to66\n(Fig.1).Thebandsfromtoptobottomare2.8,2.2,and1.8kb,respectively.\nLane52isanexampleofatumorshowingmarkedamplification(>50\ncopies)oftheEGFRgene.\npatients,evenwhenotherprognosticfactorsweretakeninto\naccount(Table4).\nRearrangementoftheHER-2/neugenewasrare.Ofthetotal189\ntumorsevaluated,threeshowedevidenceofrearrangement,andin\ntwoofthethreecases,therearrangementwasidentical(Fig.1,cases\n77to79).Also,twooftherearrangedHER-2/neulociwere\namplified(Fig.1,cases78and79).TheincidenceofHER-2/neu\nrearrangementasdeterminedbyEcoRIdigestionwastoosmallto\nattemptstatisticalcorrelations.\nTodeterminewhetherthephenomenonofamplificationofHER-\n21neuinbreastcancerextendedtorelatedgrowthfactorreceptors,\nallfilterswereanalyzedwiththeEGFRprobe(Fig.4).Amplifica-\ntionoftheEGFRgenewasfoundin4/189(2%)ofthecases,and\nrearrangementoftheEGFRgenewasfoundinoneofthosefour\ncases.TheincidenceofEGFRamplificationandrearrangementwas\ntoosmalltoattemptstatisticalcorrelation.ComparisonofHER-2/\nneuamplification(53/189or28%)withthatoftheEGFRgene\nrevealstheincidenceoftheformertobe14timesgreaterthanthat\nofthelatter,indicatingthatthephenomenonofgeneamplification\nisnotageneraloneforarelatedtyrosinekinase-specificreceptorin\nhumanbreastcancer.Moreover,studiesexaminingalterationsof\ntwoothertyrosinekinase-specificproto-oncogenes,abiandfes,in\nbreastcancerdidnotshowamplificationofthesegenes(33).\nAlterationsofnon-tyrosinekinase-relatedproto-oncogenesinthese\nTable3.AssociationbetweenHER-2/neuamplificationanddiseaseparame-\ntersincombinedsurveys(189patients).\nFactor*Single2to5 5to20 >20 Total PtCOPY copiescopiescopies\nHormnalreceptorstatus\nER+ 91 23 14 2 130 0.05\nER- 45 3 6 5 59\nPgR+ 73 20 10 3 106 0.06\nPgR- 63 6 10 4 83\nTumorsize(centimetes)\ns<2 31 9 4 0 44 0.19\n2-5 62 13 7 2 84\n>5 23 4 6 3 36\nUnknown 20 0 3 2 25\nAgeatdiagnosis(years)\n<50 37 13 8 2 60 0.11\n>50 88 13 10 5 116\nUnknown 11 0 2 0 13\nNumberofpositivelymphnodes\n0 30 0 3 1 34 0.002\n1-3 51 7 6 1 65\n>3 38 18 8 4 68\nUnknown 17 1 3 1 22\n*ERandPgRarcasdescribedinTable1. tStatisticalanalysesforcorrelationofHER-2/neuamplificationwithvariousdiseaseparameterswereperformcdbythex2test.Pvalueswerecomputedaftercombiningthecaseswith5to20and>20copies.\nSCIENCE,VOL.235\n*ERandPgRareasdescribedinTable1. tStatisticalanalysesforcorrelationof\nHER-2/neuamplificationwithvariousdiseaseparameterswereperformedbythex2test.Pvalueswerccomputedaftercombiningthe5to20and>20cases,sincethere-\nweresofewsamplesinthe>20group.\ni8o\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. ", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 5435, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "15aaa61a-7d06-4c67-92f4-a3213c3ea6b5": {"__data__": {"id_": "15aaa61a-7d06-4c67-92f4-a3213c3ea6b5", "embedding": null, "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, 1987 Study, Slamon et al., Science, Gene Expression"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "b7a39a85-e773-4c06-806b-4fb87fe99659", "node_type": "4", "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "e9cb1d1a6f2dd83c7169eee316a6650c8a9862a6c79f52c09ceb0980cc7b5ed1", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "1ee34727-4c38-46e1-abfa-61ac9b295d41", "node_type": "1", "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "e56b92629446c0e8e18f24e14c221f00f9f421b9c92f8ec47a03cacdfe4b623b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "1, 2007", "mimetype": "text/plain", "start_char_idx": 5435, "end_char_idx": 5442, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "b6a482a4-39a1-4c0a-bfa4-56b4654b2406": {"__data__": {"id_": "b6a482a4-39a1-4c0a-bfa4-56b4654b2406", "embedding": null, "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification, Breast cancer prognostic factors, Node-positive patients, Cox regression model, Proto-oncogenes in human malignancies"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd", "node_type": "4", "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "c0bf570fac52316aee5421880988264dd6f54eb29f499a658c15a82cb1737a22", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "e36249d4-a6cc-484b-93ea-81771537fa34", "node_type": "1", "metadata": {}, "hash": "9167f0742211d516fecd7936a52765c8de3e489f84ebfb17876b93c4e4a0522a", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "Table4.Univariateandmultivariateanalysescomparingdisese-freesurvival(relapse)andovrallsurvivaltoprognosticfactorsinnode-positivepatients.\nUnivariate(P) Multivariate*Factor Survival Relapse Survival Relapse\nNumberofpositivenodes 0.0001 0.0002 0.0003(0.0938\u00b10.0256) 0.001(0.0849\u00b10.Q266)HER-2/neu 0.0011 <0.0001 0.02 (0.0872\u00b10.0388) 0.001(0.1378\u00b10.0425)\nLog(PgR) 0.05 0.05\nTumorsizc 0.06 0.06\nLog(ER) 0.15 0.10 0.03(-0.5158\u00b10.2414)\nAge 0.22 0.61\n*CoxAspartialnonparametncregressionmodelwasusedtoevaluatethepredictivepowerofvariouscombinationsandinteractionsofprognosticfactorsinamultivariatemanner(42-44).ResultsareshownasP(regressioncoefficient\u00b1SE).\ntumorshavebeenexamined.Inasurveyof121primarybreast\nmalignancies,amplificationofthec-mycgenewasfoundin38\n(32%)(34).Attemptstocorrelatec-mycgeneamplificationwith\nstageofdisease,hormonalreceptorstatus,histopathologicgrade,or\naxillarynodemetastasesshowednoassociation.Therewasastatisti-\ncallysignificantassociationbetweenc-mycamplificationandagcat\ndiagnosis>50yearsinagroupof95ofthesepatients(34).Dataon\nrelapseandsurvivalwerenotpresentedinthisstudy;however,there\nwasnocorrelationbetweenc-mycamplificationandnodalstatusto\nindicateanassociationwithdiseasebehavior.\nTheexactroleofvariousproto-oncogenesinthepathogenesisof\nhumanmalignanciesremainsunclear.Onelineofevidenceimplicat-\ningabnormalitiesofthesegenesinhumandiseaseisassociationof\ntheiramplificationwithtumorprogressioninspecificcancers.The\nN-mycgeneisfrequentlyamplifiedinhumanneuroblastomasand\nneuroblastomacelllines(35,36).StudiesontheN-mycproto-\noncogenewerethefirsttoshowadirectassociationbetween\nabnormalitiesinaproto-oncogeneandclinicalbehaviorofahuman\ntumor.N-mycamplificationandexpressioncorrelatebothwithstage\nofdiseaseandoverallsurvivalinpatientswithneuroblastoma(10,\n32,37).MoreoverthegreatertheN-mycgenecopynumber,the\nworsethepatientprognosisforallstagesofthedisease(32).Taken\ntogether,thesedataindicatearolefortheN-mycgeneinthe\npathogenesisofneuroblastoma(32).\nNeuroblastomaisarelativelyrarediseasewithanincidenceofone\nper125,000children.Carcinomaofthebreast,however,isa\ncommonmalignancyaffectingoneofevery13womenintheUnited\nStates.Thereare119,000newcasesperyear,andapproximately\n40,000womenwilldieofthediseasein1986(38).Current\ntreatmentdecisionsforindividualpatientsarefrequentlybasedon\nspecificprognosticparameters.Themajorprognosticfactorsfor\nbreastcancerincludepresenceorabsenceoftumorintheaxillary\nnodes,sizeoftheprimarytumor,andpresenceorabsenceof\nhormonalreceptors(29).Thecurrentstudyindicatesthatamplifica-\ntionoftheHER-2/neugeneisasignificantpredictorofbothoverall\nsurvivalandtimetorelapseinnode-positivepatientswithbreast\ncancer.Amplificationofthegeneretainsitsprognosticsignificance\ninmultivariateanalysis,evenwhenadjustmentsaremadeforother\nknownprognosticfactors.Moreover,amplificationofHER-2/neu\nhasgreaterprognosticvaluethanmostcurrentlyusedprognostic\nfictors,includingprogesteroneandestrogenreceptors,andis\nequivalenttoandindependentofthebestknownprognosticator-\nnumberofpositivelymphnodes.Finally,thedegreeofHER-2/neu\namplificationappearstohaveaneffectonsurvival,withgreatercopy\nnumberbeingassociatedwithaworseprognosis(Fig.3,CandD).\nAsimilarphenomenonhasbeenobservedforN-mycgeneamplifica-\ntioninhumanneuroblastoma(32).\nThepotentialroleofHER-2/neuinthepathogenesisofbreast\ncancerisunknown.LikeN-myc,thecorrelationofHER-2/neu\namplficationwithdiseaseprogressionindicatesitmaybean\nimportantgeneinthediseaseprocess.Theroleofothercell\n9JANUARY1987\nreceptorsinthebiologyofbreastcanceriswellestablished(29,39,\n40).Itiseasytospeculatethatageneencodingaputativegrowth\nfactorreceptor,whenexpressedininappropriateamounts,maygive\nagrowthadvantagetothecellsexpressingit.Alternatively,alter-\nationinthegeneproductitselfmayleadtoacriticalchangeinthe\nreceptorprotein.A singlepointmutationinthetransmembrane\ndomainoftheproteinencodedbytheratneuoncogeneappearsto\nbeallthatisnecessaryforthegenetogaintransformingability(41).\nWhetherthisorasimilaralterationisfoundintheamplifiedHER-\n21neugeneinhumanbreastcancerwillrequiresequenceanalysisof\nthehomologousregionintheamplifiedhumangene.Inaddition,\nstudiesevaluatingtheexpressionofthisgeneattheRNAand/or\nproteinlevelwillproveimportantindeterminingifHER-2/neu\namplificationresultsinanexpectedincreasedgeneexpression.The\nquestionofamplificationofHER-2/neuinmetastaticascompared\ntoprimarylesionsinagivenpatientisimportant.Thecurrentstudy\nutilizedonlyprimarybreasttumorsforanalyses.Itwouldbeof\ninteresttodetermineifHER-2/neucopynumberisalteredasthe\ntumormetastasizes.ArecentstudyevaluatingN-myccopynumber\ninhumansmallcellcarcinomaofthelungshowednodifference\nbetweenprimaryandmetastaticlesions(11).\nTheinitialsurveyfromthecurrentstudyshowedthat15%of\nbreastcancerpatientswithstageIdisease(node-negative)have\nHER-2/ncuamplification.Unfortunately,nolong-termfollow-up\ndatawereavailableforthesepatients.ThisstageIsettingmaybean\nadditionalgroupinwhichHER-2/neumeasurementswillhavean\nimpactinpredictingbiologicbehaviorofthetumor,andasaresult,\nindesignoftreatmentstrategy.Finally,iftheHER-2/neugene\nproductfunctionsasagrowthfactorreceptorthatplaysaroleinthe\npathogenesisofbreastcancer,identificationofitsligandand\ndevelopmentofspecificantagonistscouldhaveimportanttherapeu-\nticimplications.\n", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 5237, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "e36249d4-a6cc-484b-93ea-81771537fa34": {"__data__": {"id_": "e36249d4-a6cc-484b-93ea-81771537fa34", "embedding": null, "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. \"Slamon et al.\", \"1987\", \"Science Journal\", \"Breast Cancer\", \"Gene Expression\""}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd", "node_type": "4", "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "c0bf570fac52316aee5421880988264dd6f54eb29f499a658c15a82cb1737a22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "b6a482a4-39a1-4c0a-bfa4-56b4654b2406", "node_type": "1", "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "5233be1f22298885b0a86390dc7d505cf298dff3e07a35b0bc6be1e4988ed6f6", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "50cdda02-4c5c-445c-b8b2-a15b3b0dfa72", "node_type": "1", "metadata": {}, "hash": "3b04d492bdabd7a3ca40435e2ec5e2cd9dea8b2467ed3173c278b76bb7f3b15f", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "REFERENCESAND NOTES\n1.J.M.Bishop,Annu.Rep.Biochm.52,301(1983).\n", "mimetype": "text/plain", "start_char_idx": 5237, "end_char_idx": 5300, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "50cdda02-4c5c-445c-b8b2-a15b3b0dfa72": {"__data__": {"id_": "50cdda02-4c5c-445c-b8b2-a15b3b0dfa72", "embedding": null, "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Cancer Research, 1984-1987, Oncogenes, Retroviruses, Genetics, Molecular Biology"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "17c63419-d9b7-4961-9dec-9f6bb88a73bd", "node_type": "4", "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "c0bf570fac52316aee5421880988264dd6f54eb29f499a658c15a82cb1737a22", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "e36249d4-a6cc-484b-93ea-81771537fa34", "node_type": "1", "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "39ed6c5ee66b31bd9c2f38d46adfd8be61651dde5ab849232d70a86225f889f2", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "2.H.E.Varmus,Annu.Rev.Genat.18,553(1984).\n3.H.Land,L.F.Parada,R.A.Weinberg,Natur(Londn)304,596(1983).\n4.H.E.Rulcy,ibid.,p.602.5.M.Schwab,H.E.Varmus,J.M.Bishop,ibid.316,160(1985).6.W.S.Hayward,B.G.Neel,S.M.Astn,ibid.290,475(1981).\n7.D.J.Slamonaat.,Scence224,256(1984).\n8.M.D.Erismanatal.,Mo.CeU.Biol.5,1969(1985).9.C.M.CroceandG.Klein,Sci.Am.252,54(March1985).10.G.M.Brodeuretat.,Scince224,1121(1984).\n11.A.J.Wongatal.,ibid.233,461(1986).\n12.J.Campisietal.,Cde33,357(1983).13.M.E.GreenbergandE.B.Zif,Nature(London)311,433(1984).14.R.Mulleretal.,ibid.299,640(1982).15.D.J.SlamonandM.J.Cline,Proc.Nad.Acad.Sci.U.S.A.81,7141(1984).16.M.D.WaterficldKal.,Natur(London)304,35(1983).\n17.R.F.Doolittle,M.W.Hunkapiller,L. E.Hood,Sdence221,275(1983).18.C.J.Sherraal.,Cel41,665(1985).19.J.Downwardetal.,Nature(London)307,521(1984).\n20.C.Shih,L.Padhy,M.Murray,R.A.Weinberg,ibid.290,261(1981).21.A.L.Schechteretal.,ibid.312,513(1984).\n22.L.Coussensetal.,Sacc230,1132(1985).23.K.Semba,N.Kamata,K.Toyoshima,T.Yamamoto,Proc.Natl.Acad.Sci.U.S.A.82,6497(1985).\nARTICLESi8i\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. 1, 2007", "mimetype": "text/plain", "start_char_idx": 5300, "end_char_idx": 6454, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "fa7b8e0b-3ac2-41bb-8b09-257bcc67c0ee": {"__data__": {"id_": "fa7b8e0b-3ac2-41bb-8b09-257bcc67c0ee", "embedding": null, "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. \"Breast Cancer\", \"Slamon et al.\", \"1987\", \"Scientific Study\", \"Application/PDF\""}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2", "node_type": "4", "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "7e2c477674d2c879b21b5e342e4bf2abc02d7e7fa8b29f038c275b98fca5ccf8", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821", "node_type": "1", "metadata": {}, "hash": "4db61cf843abeacc9ac58930bd5d99a960ca15aaa47127b6440bb5e1abdfc7b3", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "24.A.L.Schechteretal.,Scee229,976(1985).\n25.S.I.Fukushieetal.,Md.Cell.Bit.6,955(1985).\n26.C.R.King,M.H.Kraus,S.A.Aaronson,Scenc229,974(1985).27.D.MeeakkanandM.Smith,Cytgenet.Cdl.Genet.37,71(1984).\n28.A.Ulrichetal.,Natum(LI) 309,418(1984).29.G.M.Clarketal.,N.E,wl.J. Med.309,1343(1983).30.T.Maniatis,E.F.Fritch,J.Sambrook,MleularClni:A IabrtoyMaxxal,\n(ColdSpringHarborLaboratory,ColdSpnrngHarbor,NY,1982),pp.282-285.\n31.G.J.Dezikes,W.W.Grody,R.M.Kern,S.D. Caearbaum,Bioce.BEspy.Res.Commun.,in press.\n32.R.C.Seegeretat.,N.El..Med.313,1111(1985).33.J.Yokotattat.,Scenwc231,261(1986).34.C.Escotetal.,Proc.Nat.AMad.Sc.U.S.A.83,4834(1986).35.M.Schwabetal.,Nature(Lodo) 305,245(1983).\n36.N.E.Kohletat.,Cel35,359(1984).37.R.C.SeegerandD.Slamon,unpublisheddata.38.E.SilverbergandJ.Lubera,CACancerJ.Ce. 36,9(1986).39.K.B.Horwitz,W.L.McGuire,0. H.Pearson,A.Segaloff,Scenc189,726\n(1975).40.W.L.McGuire,Semin.O#C.5,428(1978).41.C.I.Bargmann,M.C.Hung,K A.Weinberg,Cell45,649(1986).42.D.R.Cox,J.R.Stat.Soc.34,187(1972).\n", "mimetype": "text/plain", "start_char_idx": 0, "end_char_idx": 1005, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821": {"__data__": {"id_": "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821", "embedding": null, "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Mengo Virus, Atomic Structure, Icosahedral Symmetry, Picornaviruses, Receptor Binding"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2", "node_type": "4", "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "7e2c477674d2c879b21b5e342e4bf2abc02d7e7fa8b29f038c275b98fca5ccf8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "fa7b8e0b-3ac2-41bb-8b09-257bcc67c0ee", "node_type": "1", "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "d58934358c221924a2a2f76e9bd73ad6378bd331e0f25afd9a855b6e4d8a412d", "class_name": "RelatedNodeInfo"}, "3": {"node_id": "3cc43232-01ca-4d26-949c-d65fe0b67268", "node_type": "1", "metadata": {}, "hash": "6e58e7b90e19edb092cfcd24b3af24765c60571ec946c038b37c189a609e685b", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "43.N.E.Breslow,I=t.Stat.Rep.43,45(1975).44.E.L.KaplanandP.Meier,J.Am.Stat.Aic.53,457(1958).45.SupportedbyU.S.PublicHealthServicegrants CA36827andCA30195anda\ngrantfiomTritnBiosciences,Inc.Wethank D. Keith,L.Gordon,andW.Aftfor\nirthnicalassistanceandDr.S.Cedarbaumforprovidingthehumanarginase\nprobe.\nThe AtomicStructureofMengo Virus\nat3.0 A Resolution\nMINGLuo,GERRITVRIEND*,GREGKAMER,IWONAMINOR,EDWARDARNOLD,\nMICHAELG.ROSSMANN,ULRIKEBOEGE,DOUGLASG.SCRABA,GREGM.DuKE,\nANNC.PALMENBERG\nIhes ofMengovirus,a repesentatve member of\nthecardiopicorn issubntially difent from the\nstr and polioviue. Ihesructe of\nMengo virus was sohledwiththeuseofhman rhinovirus\n14 as an 8 A resolutionsural aproimation. Phase\ninfirmationwas thn end to 3 resolutionbyuseof\ntheicosahedralsymmetry. lhisp ure givespromise\nthatmany other virussucs alsocan be de\nwithoutthe use oftheisomorphousreplacementtech-\nmque. Altioughtheorganiztion ofthe majorcapsid\nproteinsVP1, VP2, and VP3 of Mengo virus isessntially\nthesame asinrhino-andpoliovimses,largeinsertions\nP OICORNAVIRUSES(1)COMPRISEA LARGE FAMILYOF SINGLE-\nstrandedRNA-containinganimalviruses.Theyhavebeen\ndassifiedintofourgeneraon thebasisofphysicalproperties\nofthevirions:(i)cardioviruses,suchasencephalomyocarditisvirus\n(EMCV),Theiler'smurineencephalitisvirus,andMengovirus;(ii)\nenteroviruses,suchaspoliovirus,hepatitisAvirus,andCoxsackie\nvirus;(iii)aphthoviruses,suchasfoot-and-mouthdiseaseviruses\n(FMDV);and(iv)rhinoviruses,ofwhichthereareabout100\nserotypes.Thephysiologicalconsequencesofpicomavirusinfection\narehighlyvariablebecauseofdifferingtissuetropism,differingviral\nstabilityinacidenvironment,anddifferingresponsesbyinfected\nhostcells.Amongthemurinecardioviruses(2),forexample,Mengo\nviruscanproducefatalencephalitis,a strainofEMCV cancause\ndiabetes,andastrainofTheiler'sviruscancausechronicdemyelinat-\ningdisease.\nPicornavirionshaverelativemolecularmassofabout8.5x 106\ndaltons,ofwhichabout30percentisRNA.Theviruspartidesare\nsphericalwithan externaldiameterofabout300A.Thecoat\nproteinsformashellwithicosahedralsymmenywith60protomers,\n182\nanddeletions,mostlyinVP1,radicallyalterthesurface\nfeatures.Inparticular,theputativereceptorbinding\n\"canyon\"ofhuman rhinovirus14becomesadeep\"pit\"in\nMengovirusbecauseofpolypeptide insertionsinVP1\nthatfillpartofthecanyon.The minor capsidpeptide,\nVP4,iscompletelyintenal inMengo virus,butits\nassociation withtheothercapsidproteis issubstantially\ndifferentfromthatinrhino-orpoliovirus. However,its\ncarboxyl terminus islocatedatapositionsimilartothatin\nhuman rhinovirus 14and poliovirs, suggesting te same\nautocatalytic ldeavageof VPO to VP4 andVP2 takes place\nduring assembly inallthesepicornaviruses.\neachcomposedofasinglecopyofVP1,VP2,VP3,andVP4(Fig.\n1)withapproximaterelativemolecularmassesof34,000,30,000,\n25,000,and7,000daltons,respectively.ForMengovirus,the\nproteinsconsistof277,256,231,and70aminoacids,respectively.\nOndegradingMengovirus,thevirionsseparateinto13.4Spen-\ntamersandtheninto6Sprotomers(3,4)consistentwithstructural\nobservations(5).Traditionally,thecardioviruscapsidproteinshave\nboendesignateda,, , and8inorderofdecreasingsize;theVP1\n(a),VP2 (1),VP3 (y),VP4 (6)nomencature isused in-thisartide\ninordertofacilitatecomparisonwithotherpicomaviruses.Theviral\nM.Luo,G.Vriend,G.Kamer,I.Minor,E.Amokl,andM.G.R an whodidtheaystlgbicanalysis,areintheDepar ofBiologicalSciences,PurdueUniver-\nsity,WesLafayet,IN47907.U.BoegeandD.G.Scraba,whoproducedandpurifiedthe60milligramsofvirusused,areintheDepartmeofBiochemistry,UniversityofAlberta,Edmonton,AlbertaT6G2H7,Canada.G.M.DukeandA.C.Palmenberg,whodectminedhscqunceoftheviralRNA,areindtBiophysicalLaboratoryoftieGraduateSchool,Uni tyofWisoin,Maison,WI53706.\n*Praentaddress:DeparmtofStrucuralChemistry,UniversityofGroningen,Nijcnborgh16,9747AGGro9inn,TheNetherlands.\n", "mimetype": "text/plain", "start_char_idx": 1005, "end_char_idx": 4795, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}, "3cc43232-01ca-4d26-949c-d65fe0b67268": {"__data__": {"id_": "3cc43232-01ca-4d26-949c-d65fe0b67268", "embedding": null, "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, 2. Gene Expression Profiling, 3. Oncology, 4. Molecular Biomarkers, 5. Tumor Markers"}, "excluded_embed_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "excluded_llm_metadata_keys": ["file_name", "file_type", "file_size", "creation_date", "last_modified_date", "last_accessed_date"], "relationships": {"1": {"node_id": "96f2ff6b-ee85-4340-81f6-dd6113e94fe2", "node_type": "4", "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "7e2c477674d2c879b21b5e342e4bf2abc02d7e7fa8b29f038c275b98fca5ccf8", "class_name": "RelatedNodeInfo"}, "2": {"node_id": "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821", "node_type": "1", "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01"}, "hash": "fb661db307fbd32185c92d28b5e14ae5924f5773d2589959d9ff02cc48da72bc", "class_name": "RelatedNodeInfo"}}, "metadata_template": "{key}: {value}", "metadata_separator": "\n", "text": "SCIENCE,VOL.235\n on January 15, 2007 www.sciencemag.orgDownloaded from \nBIOM 255 (Leffert) \u2013 Discussion Feb. 1, 2007\nView publication stats", "mimetype": "text/plain", "start_char_idx": 4795, "end_char_idx": 4934, "metadata_seperator": "\n", "text_template": "[Excerpt from document]\n{metadata_str}\nExcerpt:\n-----\n{content}\n-----\n", "class_name": "TextNode"}, "__type__": "1"}}, "docstore/ref_doc_info": {"dcccb590-ced7-4448-be67-8ee7b08feb32": {"node_ids": ["fba8bad4-3a45-41a8-9224-94c571042533", "3c22b8fc-c33f-4bb4-9b3b-959b594afbf7"], "metadata": {"page_label": "1", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, HER-2/neu Oncogene, Amplification, Relapse, Survival"}}, "25d082c3-d393-4ad8-a079-1e89e75c3a90": {"node_ids": ["2b971f14-46c7-49f1-ba05-b2a52950a828", "df3543ea-04ae-48bc-9b7d-f5e36d4cce6b"], "metadata": {"page_label": "2", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. Breast Cancer, HER-2/neu Oncogene, Survival Rate, Amplification, Science Magazine (1987)"}}, "157678dc-b38b-4693-b309-53b462c7d973": {"node_ids": ["e277d928-6806-42d8-a6b7-1d4425d45b3e", "5d2a5bf1-d552-412f-ae29-0034b717760e"], "metadata": {"page_label": "3", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu Oncogene, Breast Cancer, Gene Amplification, Survival Rate, Prognostic Factors"}}, "ce7f02c9-a003-4187-8c05-693f2a35c93e": {"node_ids": ["791b4551-a4f6-4561-827a-1e85866ed80d", "6f61f65c-0662-4e27-b65c-cf9de9ad1028"], "metadata": {"page_label": "4", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification,\n   2. Breast cancer,\n   3. Oncogene abnormalities,\n   4. Southern blot analysis,\n   5. Prognosis of breast malignancies"}}, "0a9fc226-d7bc-402d-b751-055d250fdb2c": {"node_ids": ["499d6266-adcb-4074-b6a8-7e4a6012a260", "6e631bfa-8786-44e5-9505-5426e3e2a57b"], "metadata": {"page_label": "5", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification, Breast cancer, Gene amplification analysis, Axillary lymph nodes, Multivariate regression analysis"}}, "b7a39a85-e773-4c06-806b-4fb87fe99659": {"node_ids": ["1ee34727-4c38-46e1-abfa-61ac9b295d41", "15aaa61a-7d06-4c67-92f4-a3213c3ea6b5"], "metadata": {"page_label": "6", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu amplification,\n   2. Breast cancer,\n   3. Gene amplification,\n   4. Disease behavior,\n   5. Survival analysis"}}, "17c63419-d9b7-4961-9dec-9f6bb88a73bd": {"node_ids": ["b6a482a4-39a1-4c0a-bfa4-56b4654b2406", "e36249d4-a6cc-484b-93ea-81771537fa34", "50cdda02-4c5c-445c-b8b2-a15b3b0dfa72"], "metadata": {"page_label": "7", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. HER-2/neu gene amplification, Breast cancer prognostic factors, Node-positive patients, Cox regression model, Proto-oncogenes in human malignancies"}}, "96f2ff6b-ee85-4340-81f6-dd6113e94fe2": {"node_ids": ["fa7b8e0b-3ac2-41bb-8b09-257bcc67c0ee", "81bd6a0e-b6df-4699-bd1e-2a7ea7c19821", "3cc43232-01ca-4d26-949c-d65fe0b67268"], "metadata": {"page_label": "8", "file_name": "SlamonetalSCIENCE1987.pdf", "file_path": "SlamonetalSCIENCE1987.pdf", "file_type": "application/pdf", "file_size": 2089288, "creation_date": "2025-05-02", "last_modified_date": "2025-05-01", "excerpt_keywords": "1. \"Breast Cancer\", \"Slamon et al.\", \"1987\", \"Scientific Study\", \"Application/PDF\""}}}}